Protalix BioTherapeutics (PLX) Reports FY Loss of $0.08
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.29 +3.15%
Financial Fact:
COST OF REVENUES: -4.25M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
COST OF REVENUES: -4.25M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported FY EPS of ($0.08). Revenue for the period came in at $52.74 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- CalPrivate Bank names Andra Frazier as chief credit officer
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
